The FDA announced on September 2, 2025, that Major Pharmaceuticals is recalling Sulfamethoxazole and Trimethoprim tablets due to a foreign substance hazard. The recall involves specific lots distributed nationwide in the United States.
How to tell if you have it
- Brand: Major Pharmaceuticals
- Product: Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister pack (10x1)
- NDC: 55154-7895-0 (Outer Bag) containing NDC 0904-2725-61 (Inner blisters)
- Bag codes: N02309A and N02309B
- Inner blister lot: N02309
- Expiration date: 03/31/2027
The hazard
The FDA said the hazard is the presence of a foreign substance, specifically a micro-organism detected on a specific lot of auxiliary polyester coil used in product packaging by manufacturer Amneal Pharmaceuticals LLC. No micro-organism was detected on any tablets.
Context
GovInfoNow's records show The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories has 14 other recalls on record since May 31, 2023. Recent similar recalls include the Major Chlorpromazine 100mg Tablets Recall (September 12, 2025) and the Major Pharmaceuticals Carvedilol Tablets Recall (August 20, 2025). Other recent recalls of similar products include the Bionpharma Divalproex Tablets Recall (June 26, 2026), the Graviti Furosemide Tablets Recall (January 10, 2026), and the Amerisource Health Primidone Tablets Recall (May 1, 2026).